-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Hepatocellular Carcinoma (HCC)
Overview How likely is it that the drugs in Metastatic Hepatocellular Carcinoma (HCC) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Hepatocellular Carcinoma (HCC) Overview Metastatic hepatocellular carcinoma (HCC) refers...
-
Product Insights
NewLikelihood of Approval Analysis for Relapsed Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that the drugs in Relapsed Chronic Lymphocytic Leukemia (CLL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Relapsed Chronic Lymphocytic Leukemia (CLL) Overview Relapsed Chronic Lymphocytic...
-
Product Insights
NewLikelihood of Approval Analysis for Mucopolysaccharidosis
Overview How likely is it that the drugs in Mucopolysaccharidosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mucopolysaccharidosis Overview Mucopolysaccharidosis (MPS) refers to a group of inherited metabolic disorders causing...
-
Product Insights
NewLikelihood of Approval Analysis for Musculoskeletal Inflammation
Overview How likely is it that the drugs in Musculoskeletal Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Musculoskeletal Inflammation Overview Musculoskeletal inflammation refers to the body's response to irritation,...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Metastasis
Overview How likely is it that the drugs in Bone Metastasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Metastasis Overview Bone metastasis occurs when cancer cells spread from their...
-
Product Insights
NewLikelihood of Approval Analysis for Arthritis Pain
Overview How likely is it that the drugs in Arthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Pain Overview Arthritis pain stems from inflammation in joints, causing discomfort,...
-
Product Insights
NewLikelihood of Approval Analysis for Bipolar I Disorder
Overview How likely is it that the drugs in Bipolar I Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bipolar I Disorder Overview Bipolar I Disorder is a mental health...
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Neuropathic Pain
Overview How likely is it that the drugs in Diabetic Neuropathic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Neuropathic Pain Overview Diabetic neuropathic pain arises from nerve damage...
-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Neuropathic Pain
Overview How likely is it that the drugs in Peripheral Neuropathic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Neuropathic Pain Overview Peripheral neuropathic pain refers to a type...
-
Product Insights
NewLikelihood of Approval Analysis for Mixed Pain (Nociceptive Pain/Neuropathic Pain)
Overview How likely is it that the drugs in Mixed Pain (Nociceptive Pain/Neuropathic Pain) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mixed Pain (Nociceptive Pain/Neuropathic Pain) Overview Mixed pain involves...